Pre-Basal Insulin Analog Era: Paving the Way for Modern Day Basal Insulins.
| Autor: | Tiwaskar M; Senior Consultant, Shilpa Medical Research Center, Mumbai, Maharashtra., Deb P; Head, Department of Endocrinology, KIMS Hospital, Hyderabad, Telangana., Khadgawat R; Professor, Department of Endocrinology, All India Institute of Medical Sciences, Delhi., Sreenivasamurthy L; Consultant, Life care clinic and research center, Bengaluru, Karnataka., Deka N; Consultant, Apollo Hospital, Guwahati, Assam., Karthik B; Assistant Professor, Endocrinology, Sri Ramachandra Medical College, Chennai, Tamil Nadu., Karuppan A; Consultant, Tambaram Medical Centre, Chennai, Tamil Nadu., Bhattacharjee D; Medical Affairs, Diabetes and Cardiovascular, Sanofi India Ltd., Mohan V; Chairman and Chief Diabetologist, Dr. Mohan's Diabetes Specialities Centre, Chennai, Tamil Nadu. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The Journal of the Association of Physicians of India [J Assoc Physicians India] 2020 Dec; Vol. 68 (12[Special]), pp. 9-12. |
| Abstrakt: | Prior to the discovery of insulins, diabetes was managed predominantly by dietary interventions. Discovery of insulin and its first human trial highlighted the need for higher purity insulin thereby steering the subsequent journey of insulin development. Considering the limitations of the early preparations like short duration of action and need for several injections per day, attempts at protracting the duration of insulin action were made. This led to the development of intermediate-acting Neutral Protamine Hagedorn (NPH) and the Lente family of insulins. This review provides insights into the discovery of insulins and the shortcomings of early protracted release preparations, which in turn, gave impetus to the search for a 'true' basal insulin, which could mimic the endogenous human basal insulin secretion. (© Journal of the Association of Physicians of India 2011.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|